2026 ICD-10-CM Diagnosis Code R87.624Cytologic evidence of malignancy on smear of vagina

ICD-10-CM Codes›R00–R99›R83-R89›R87

ICD-10-CM R87.624
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

R87.624 is a billable ICD-10-CM diagnosis code for cytologic evidence of malignancy on smear of vagina. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 742 through 743, 760 through 761. As a symptom code, it should not be used as a principal diagnosis once a related definitive diagnosis has been established. Coders also document this condition as abnormal vaginal Papanicolaou smear. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Abnormal findings without diagnosis.

Code Identity

ICD-10-CM Code
R87.624
Billable Status
Yes — Valid for Submission
Code Describes
Cytologic evidence of malignancy on smear of vagina
Short Description
Cytologic evidence of malignancy on smear of vagina
Same as the full description in the CMS dataset.
Parent Code
R87.62
Abnormal cytological findings in specimens from vagina

Code Classification

ChapterR00–R99Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
SectionR83-R89Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
CategoryR87Abnormal findings in specimens from female genital organs
This CodeR87.624Cytologic evidence of malignancy on smear of vagina

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Abnormal vaginal Papanicolaou smear
  • Cytological evidence of malignancy on vaginal Papanicolaou smear
  • Detected by cytology
  • Malignant neoplasm detected by Papanicolaou smear of vagina

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Abnormal, abnormality, abnormalities
      • Papanicolaou (smear)
        • vagina
          • cytologic evidence of malignancy
    • Evidence
      • cytologic
        • of malignancy on vaginal smear

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR SYM017
Abnormal findings without diagnosis
Default principal diagnosis: inpatient Yes · outpatient Yes

Convert R87.624 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
795.16 Pap smr vag-cytol malig
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About R87.624Overview

Is R87.624 (Abnormal cytological findings in specimens from vagina) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report cytologic evidence of malignancy on smear of vagina on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does R87.624 group to?

When cytologic evidence of malignancy on smear of vagina is the principal diagnosis on an inpatient stay, it groups to MS-DRG 742, 743, 760, 761, with relative weights from 0.5696 to 1.8348 depending on complications. Higher weights mean higher Medicare reimbursement.

Can R87.624 be a principal diagnosis?

Use it with care. This is a symptom code, so once a definitive diagnosis explaining the cytologic evidence of malignancy on smear of vagina is established, that condition takes the principal position instead.

What is the ICD-9 equivalent of R87.624?

Under the General Equivalence Mappings, cytologic evidence of malignancy on smear of vagina converts to ICD-9-CM 795.16 (pap smr vag-cytol malig). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.